Form 8-K - Current report:
SEC Accession No. 0001493152-25-003425
Filing Date
2025-01-23
Accepted
2025-01-23 17:00:22
Documents
33
Period of Report
2025-01-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42856
2 ex2-1.htm EX-2.1 12823
3 ex2-1_001.jpg GRAPHIC 932925
4 ex2-1_002.jpg GRAPHIC 958434
5 ex2-1_003.jpg GRAPHIC 1028944
6 ex2-1_004.jpg GRAPHIC 962326
7 ex2-1_005.jpg GRAPHIC 1070747
8 ex2-1_006.jpg GRAPHIC 1051324
9 ex2-1_007.jpg GRAPHIC 1068619
10 ex2-1_008.jpg GRAPHIC 1125366
11 ex2-1_009.jpg GRAPHIC 1176893
12 ex2-1_010.jpg GRAPHIC 1024692
13 ex2-1_011.jpg GRAPHIC 1114711
14 ex2-1_012.jpg GRAPHIC 1250617
15 ex2-1_013.jpg GRAPHIC 1017533
16 ex2-1_014.jpg GRAPHIC 1184122
17 ex2-1_015.jpg GRAPHIC 772134
18 ex2-1_016.jpg GRAPHIC 977753
19 ex2-1_017.jpg GRAPHIC 698580
20 ex2-1_018.jpg GRAPHIC 327467
21 ex2-1_019.jpg GRAPHIC 155880
  Complete submission text file 0001493152-25-003425.txt   24883417

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE prph-20250116.xsd EX-101.SCH 3027
23 XBRL LABEL FILE prph-20250116_lab.xml EX-101.LAB 34240
24 XBRL PRESENTATION FILE prph-20250116_pre.xml EX-101.PRE 24173
35 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3799
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

EIN.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 25550858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)